Study to Evaluate the Therapeutic Equivalence and Safety of Fluticasone Furoate and Vilanterol Inhalation Powder 100 mcg/25 mcg and BREO ELLIPTA 100 mcg/25 mcg in Participants With Asthma
Clinical trial NCT07223294 · WITHDRAWN
Trial details
- NCT number
- NCT07223294
- Sponsor
- Sandoz
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-21
- Primary completion
- 2026-04-21
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.